Pallab Ghosh

Pallab is a team member at Flusso Capital where he focuses on venture investments in companies that translate groundbreaking science into innovative medicines. Prior to joining Flusso Capital, he was a senior member at Nona Biosciences and Biocytogen, where he led and supported business development activities across multiple therapeutic areas.

He previously served as founding scientific team member at Affinivax Inc (acquired by GSK) and Combined Therapeutics, where he led IND-enabling studies to advance and mature a collection of drug development programs for vaccines and therapeutics. Pallab earned his PhD in biomedical sciences from University of Wisconsin–Madison before completing his postdoctoral training at Harvard Medical School. Outside of work, Pallab enjoys being outdoors and community activities, cooking, and spending time with his wife and two children.